Genmab reported DKK21M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Agios Pharmaceuticals USD 37.84M 2.09M Sep/2026
Almirall EUR 173.45M 4.68M Jun/2026
Amarin USD 158.85M 5.22M Sep/2026
Amgen USD 6.39B 169M Sep/2026
argenx SE USD 371M 102.53M Jun/2026
AstraZeneca USD 6.93B 362M Jun/2026
Bayer EUR 11.97B 43M Jun/2026
BioMarin Pharmaceutical USD 1.8B 13.54M Sep/2026
Demant DKK 2.81B 187M Jun/2026
Exelixis USD 29.87M 1.14M Sep/2026
Fresenius Medical Care EUR 2.41B 81.49M Sep/2026
Genmab DKK 21M 8M Mar/2026
GlaxoSmithKline GBP 6.28B 125M Jun/2026
GN Store Nord DKK 2.07B 233M Sep/2026
GRIFOLS EUR 3.47B 23M Sep/2026
Hikma Pharmaceutical USD 1.11B 24M Dec/2025
Insmed USD 163.95M 21.56M Sep/2026
Lakefront Biotherapeutics EUR 17.69M 4.8M Mar/2026
Lonza CHF 1.68B 163M Dec/2025
Merck EUR 4.89B 104M Jun/2026
Novartis USD 6.1B 116M Sep/2026
Regeneron Pharmaceuticals USD 2.89B 189.7M Sep/2026
Roche Holding CHF 7.6B 9M Jun/2025
Sanofi EUR 24.12B 620M Jun/2026
UCB EUR 1.31B 173M Dec/2024